256 related articles for article (PubMed ID: 26361417)
21. Changing strategies for target therapy in gastric cancer.
Lee SY; Oh SC
World J Gastroenterol; 2016 Jan; 22(3):1179-89. PubMed ID: 26811656
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
23. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
24. Current and emerging therapies in unresectable and recurrent gastric cancer.
Jou E; Rajdev L
World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
[TBL] [Abstract][Full Text] [Related]
25. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptors in gastric cancer: Advances and perspectives.
Ur Rahman MS; Cao J
World J Gastroenterol; 2016 Feb; 22(8):2475-82. PubMed ID: 26937135
[TBL] [Abstract][Full Text] [Related]
27. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
[TBL] [Abstract][Full Text] [Related]
28. The gene encoding the mouse contactin-1 axonal glycoprotein is regulated by the collier/Olf1/EBF family early B-Cell factor 2 transcription factor.
Bizzoca A; Picocci S; Corsi P; Arbia S; Croci L; Consalez GG; Gennarini G
Dev Neurobiol; 2015 Dec; 75(12):1420-40. PubMed ID: 25820347
[TBL] [Abstract][Full Text] [Related]
29. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
30. CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer.
Choi ES; Kim H; Kim HP; Choi Y; Goh SH
Sci Rep; 2017 Jul; 7(1):4930. PubMed ID: 28694503
[TBL] [Abstract][Full Text] [Related]
31. cMET as a potential therapeutic target in gastric cancer (Review).
Teng L; Lu J
Int J Mol Med; 2013 Dec; 32(6):1247-54. PubMed ID: 24141315
[TBL] [Abstract][Full Text] [Related]
32. Roles of long non-coding RNAs in gastric cancer metastasis.
Yang ZG; Gao L; Guo XB; Shi YL
World J Gastroenterol; 2015 May; 21(17):5220-30. PubMed ID: 25954095
[TBL] [Abstract][Full Text] [Related]
33. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice.
Abbas M; Habib M; Naveed M; Karthik K; Dhama K; Shi M; Dingding C
Biomed Pharmacother; 2017 Nov; 95():1082-1090. PubMed ID: 28922727
[TBL] [Abstract][Full Text] [Related]
34. Molecular targeted therapy for the treatment of gastric cancer.
Xu W; Yang Z; Lu N
J Exp Clin Cancer Res; 2016 Jan; 35():1. PubMed ID: 26728266
[TBL] [Abstract][Full Text] [Related]
35. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
36. Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications.
Abdel-Rahman O
Expert Rev Anticancer Ther; 2015 Feb; 15(2):235-45. PubMed ID: 25353620
[TBL] [Abstract][Full Text] [Related]
37. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy for gastric adenocarcinoma.
Almhanna K
Adv Pharmacol; 2012; 65():437-70. PubMed ID: 22959034
[TBL] [Abstract][Full Text] [Related]
39. Emerging molecular basis of hematogenous metastasis in gastric cancer.
Zhong J; Chen Y; Wang LJ
World J Gastroenterol; 2016 Feb; 22(8):2434-40. PubMed ID: 26937132
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.
Jiang C; Chen X; Alattar M; Wei J; Liu H
Cancer Gene Ther; 2015 Jun; 22(6):291-301. PubMed ID: 25998522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]